Clinical Trials Logo

Clinical Trial Summary

This is a single-center, prospective, randomized (1:1), open-label study with two parallel groups. This study is planned to investigate the efficacy and safety of dabigatran etexilate comparing with warfarin for the treatment of cerebral venous thrombosis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03217448
Study type Interventional
Source Capital Medical University
Contact Xunming Ji
Phone +86-83198952
Email jixunming@vip.163.com
Status Recruiting
Phase Phase 3
Start date October 30, 2017
Completion date January 2019

See also
  Status Clinical Trial Phase
Completed NCT00924859 - The Role of Factor XIII Activation Peptide and D-dimer Values for the Diagnosis of Cerebral Venous Thrombosis (CVT)
Recruiting NCT03747081 - Efficacy Comparison of Warfarin Versus Rivaroxaban CVT Phase 1/Phase 2
Recruiting NCT04660747 - Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis
Completed NCT03178864 - Study of Rivaroxaban for CeREbral Venous Thrombosis Phase 2
Recruiting NCT04972058 - Philippine Neurological Association One Database - Stroke
Completed NCT02013635 - Thrombin Generation and Thrombus Degradation in Cerebral Venous Thrombosis : Clinical and Radiological Correlations N/A
Completed NCT06266585 - Clinical Deterioration in Cerebral Venous Thrombosis: A Predictive Study
Completed NCT05990894 - Steroid for Treatment of Acute/Subacute Severe Cerebral Venous Thrombosis.
Completed NCT03033966 - Evaluation of Cerebral Oxygenation and Hemodynamics in Patients With Cerebral Venous Thrombosis N/A
Not yet recruiting NCT03191305 - Comparison of the Efficacy of Rivroxaban to Coumadin( Warfarin ) in Cerebral Venous Thrombosis N/A
Recruiting NCT05491980 - Florida Cerebrovascular Disease Biorepository and Genomics Center
Completed NCT01796015 - Intracranial Hypertension and Optic Nerve Sheath Diameter N/A